VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ICLRICON Public Limited Company
$146.00$11.2B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksICLRPrice Target
ICLR logo

ICON Public Limited Company (ICLR) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Buy
Based on 30 analysts

4.2% Above Target

ICLR trades 4.2% above Wall Street's consensus target of $139.90.

Current Price$146.00
Average Target$139.90
Target
Current
Low$100.00
Median$135.50
High$216.00

Analyst Target Range

Forward P/E13.8x
(Value)
PEG Ratio—
Implied Growth+70.5%
(High Growth)
Analyst Spread82.9%
(Wide Disagreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$146.00
Consensus$139.90
High$216.00
Low$100.00

Consensus Scenario Assumptions

The base valuation assumes ICLR achieves its forward estimates and maintains a stable P/E multiple of 13.8x. This scenario reflects the blended consensus of 30 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 30 published analyst recommendations for ICLR

43% hold / mixed conviction
+22
BearishBullish
Weighted analyst sentiment score based on 30 ratings
ConsensusBuy
Coverage30 Analysts
Net Score+22
Bull / Bear50% / 7%
Strong Buy00%
Buy1550%
Hold1343%
Sell27%
Strong Sell00%
Strong Buy
00%
Buy
1550%
Hold
1343%
Sell
27%
Strong Sell
00%
Recommendation Mix50% Buy · 43% Hold · 7% Sell
Buy (15)Hold (13)Sell (2)

ICLR Price Target Analysis

Updated June 21, 2026

As of June 21, 2026, ICON Public Limited Company (ICLR) has a Wall Street consensus price target of $139.90, based on estimates from 30 covering analysts. With the stock currently trading at $146.00, this represents a potential downside of -4.2%. The company has a market capitalization of $11.18B.

Analyst price targets range from a low of $100.00 to a high of $216.00, representing a 83% spread in expectations. The median target of $135.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.

The current analyst consensus rating is Buy, with 15 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 2 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, ICLR trades at a trailing P/E of 50.3x and forward P/E of 13.8x. Analysts expect EPS to grow +70.5% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $419.21, with bear and bull scenarios of $264.10 and $552.35 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+23.4%
Industry Consensus
Avg Forward P/E
18.6x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
CRL logo
CRLCharles River Laboratories International, Inc.
$8.9B$185.00$214.14
+15.8%
Buy16.7x37
IQV logo
IQVIQVIA Holdings Inc.
$28.5B$167.77$219.44
+30.8%
Buy13.1x44
MEDP logo
MEDPMedpace Holdings, Inc.
$13.1B$460.20$498.86
+8.4%
Hold27.1x19
PRA logo
PRAProAssurance Corporation
$1.3B$24.65$18.33
-25.6%
Hold20.1x11
LH logo
LHLabcorp Holdings Inc.
$21.1B$255.82$311.33
+21.7%
Buy14.2x35
DGX logo
DGXQuest Diagnostics Incorporated
$21.6B$195.00$220.57
+13.1%
Hold18.1x34
NVCR logo
NVCRNovoCure Limited
$1.6B$14.28$33.00
+131.1%
Buy—15
HIMS logo
HIMSHims & Hers Health, Inc.
$7.8B$35.47$28.08
-20.8%
Hold—20
TMO logo
TMOThermo Fisher Scientific Inc.
$172.7B$464.61$599.70
+29.1%
Buy18.7x42
DHR logo
DHRDanaher Corporation
$125.4B$177.17$230.89
+30.3%
Buy21.0x43

ICLR — Frequently Asked Questions

Quick answers to the most common questions about buying ICLR stock.

What is the ICLR stock price target for 2026?

Wall Street's consensus price target for ICLR is $139.9, -4.2% from its current price of $146. The below-market target from 30 analysts suggests limited near-term appreciation.

Is ICLR a buy, sell, or hold?

ICLR has a consensus rating of "Buy" based on 30 Wall Street analysts. The rating breakdown is mixed, with 13 Hold ratings making up the largest segment. The consensus 12-month price target of $139.9 implies -4.2% downside from current levels.

Is ICLR stock overvalued or undervalued?

With a forward P/E of 13.8381x, ICLR trades at a relatively low valuation. The consensus target of $139.9 implies -4.2% move, suggesting the market may be pricing in risks.

How high can ICLR stock go?

The most bullish Wall Street analyst has a price target of $216 for ICLR, while the most conservative target is $100. The consensus of $139.9 represents the median expectation. Our quantitative valuation model projects a bull case target of $552 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover ICLR stock?

ICLR is heavily covered by Wall Street, with 30 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 15 have Buy ratings, 13 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the ICLR stock forecast?

The 12-month ICLR stock forecast based on 30 Wall Street analysts shows a consensus price target of $139.9, with estimates ranging from $100 (bear case) to $216 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $419, with bear/bull scenarios of $264/$552.

What is ICLR's fair value based on fundamentals?

Our quantitative valuation model calculates ICLR's fair value at $419 (base case), with a bear case of $264 and bull case of $552. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.

What is ICLR's forward P/E ratio?

ICLR trades at a forward P/E ratio of 13.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 50.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy ICLR stock?

Analysts are cautious on ICLR, with 2 Sell ratings and a price target of $139.9 (-4.2% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do ICLR price targets vary so much?

ICLR analyst price targets range from $100 to $216, a 83% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $139.9 consensus represents the middle ground. Our model's $264-$552 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into ICLR consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare